BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 33684832)

  • 1. Isolated myelitis in a patient with Behcet's disease during golimumab therapy.
    Kon T; Hasui K; Suzuki C; Nishijima H; Tomiyama M
    J Neuroimmunol; 2021 May; 354():577533. PubMed ID: 33684832
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Golimumab therapy-induced isolated myelitis in a Behcet's disease patient: a case report.
    Kudsi M; Shahada Z; Haidar G; Safiah MH; Khalayli N
    Ann Med Surg (Lond); 2023 Apr; 85(4):951-954. PubMed ID: 37113905
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Subacute longitudinal myelitis associated with Behcet's disease.
    Fukae J; Noda K; Fujishima K; Takahashi T; Hattori N; Okuma Y
    Intern Med; 2010; 49(4):343-7. PubMed ID: 20154443
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Acute myelitis and Behcet's disease: three case reports].
    Harmouche H; Mouti O; el-Alaoui Faris M; Aidi S; Benabdeljalil M; Chkili T
    Rev Med Interne; 2000 Dec; 21(12):1047-51. PubMed ID: 11191672
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Behcet's disease with peripheral nervous system involvement successfully treated with golimumab: a case report and review of the literature.
    Yao M; Gao C; Zhang C; Di X; Liang W; Sun W; Wang Q; Zheng Z
    Rheumatol Int; 2021 Jan; 41(1):197-203. PubMed ID: 32676898
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-Tumor Necrosis Factor Therapy in Intestinal Behçet's Disease.
    Park J; Cheon JH
    Gut Liver; 2018 Nov; 12(6):623-632. PubMed ID: 29788675
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Longitudinally extensive transverse myelitis as the sole presentation of neuro-Behçet's disease responding to infliximab.
    Coulter I; Huda S; Baborie A; Jacob A
    J Spinal Cord Med; 2012 Mar; 35(2):122-4. PubMed ID: 22333754
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical and imaging features of spinal cord type of neuro Behçet disease: A case report and systematic review.
    Liu HM; Dong C; Zhang YZ; Tian YY; Chen HX; Zhang S; Li N; Gu P
    Medicine (Baltimore); 2017 Oct; 96(40):e7958. PubMed ID: 28984755
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Spinal cord involvement in Behçet's disease.
    Lee HS; Kim do Y; Shin HY; Choi YC; Kim SM
    Mult Scler; 2016 Jun; 22(7):960-3. PubMed ID: 26480923
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Longitudinal Myelitis of a Neuro-Behçet Patient.
    Tang Q; Tian J
    Arch Rheumatol; 2016 Mar; 31(1):91-93. PubMed ID: 29900982
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multifocal myelitis in Behçet's disease.
    Moskau S; Urbach H; Hartmann A; Schmidt S
    Neurology; 2003 Feb; 60(3):517. PubMed ID: 12578943
    [No Abstract]   [Full Text] [Related]  

  • 12. Long-term efficacy and safety of golimumab in the treatment of multirefractory Behçet's disease.
    Vitale A; Emmi G; Lopalco G; Fabiani C; Gentileschi S; Silvestri E; Gerardo DS; Iannone F; Frediani B; Galeazzi M; Lapadula G; Rigante D; Cantarini L
    Clin Rheumatol; 2017 Sep; 36(9):2063-2069. PubMed ID: 28401434
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Real-world efficacy of adalimumab and infliximab for refractory intestinal Behçet's disease.
    Sugimura N; Mizoshita T; Sugiyama T; Togawa S; Miyaki T; Suzuki T; Tanida S; Kataoka H; Sasaki M
    Dig Liver Dis; 2019 Jul; 51(7):967-971. PubMed ID: 30872086
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recurrent longitudinal extensive transverse myelitis in a neuro-Behçet syndrome treated with infliximab.
    Uygunoğlu U; Pasha M; Saip S; Siva A
    J Spinal Cord Med; 2015 Jan; 38(1):111-4. PubMed ID: 24673549
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of myelitis in Behçet's disease with rituximab.
    Messina MJ; Rodegher M; Scotti R; Martinelli V
    BMJ Case Rep; 2014 May; 2014():. PubMed ID: 24879733
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Whole thoracal spinal cord involvement in case of neuro-Behçet's disease.
    Kabukçu T; Edemci S; Uçan H; Celik C; Gunes HN; Yoldas T
    Rheumatol Int; 2009 Apr; 29(6):707-9. PubMed ID: 18982328
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of infliximab in neuro-Behçet's disease presenting with isolated longitudinally extensive transverse myelitis.
    Kuroda R; Suzuki J; Muramatsu M; Tasaki A; Yano M; Imai N; Serizawa M; Kobari M
    J Neurol; 2013 Dec; 260(12):3167-70. PubMed ID: 24178704
    [No Abstract]   [Full Text] [Related]  

  • 18. Anesthetic Management of an Obstetric Patient with Behçet's Disease Complicated by Transverse Myelitis.
    Alwatban S; AlAamri E; Alraffa A; Alkhawajah M
    Case Rep Anesthesiol; 2022; 2022():3082743. PubMed ID: 35251717
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transverse myelitis in a patient with Behcet's disease: favorable outcome with a combination of interferon-alpha.
    Calgüneri M; Onat AM; Oztürk MA; Ozçakar L; Ureten K; Akdogan A; Ertenli I; Kiraz S
    Clin Rheumatol; 2005 Feb; 24(1):64-6. PubMed ID: 15517447
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative study of corticosteroid monotherapy, and TNF inhibitors with or without corticosteroid in patients with refractory entero-Behcet's disease.
    Miyagawa I; Nakano K; Iwata S; Nakayamada S; Saito K; Hanami K; Fukuyo S; Kubo S; Kawabe A; Miyazaki Y; Tanaka Y
    Arthritis Res Ther; 2019 Jun; 21(1):151. PubMed ID: 31228955
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.